Indonesia's Inflation Rose to 1.87% in Jun-25

MACROECONOMY 
The Fed Held Rate Cuts Due to Trump's Tariff Threats 
Fed Chair Jerome Powell signaled that the US central bank would have cut rates further in 2025 if not for Trump's aggressive tariff expansion, which has lifted inflation forecasts. Speaking at the ECB Forum on 1 Jul-25, Powell stated the Fed is in a “wait-and-see” mode to assess the inflationary impact of tariffs. Currently, Fed projections remain split, with 10 officials expecting at least two cuts in 2025, while others see none. Powell reiterated the Fed's commitment to its mandate despite political pressures. (Bloomberg Technoz) 
 

Indonesia's Inflation Rose to 1.87% in Jun-25 

Indonesia's inflation rose to 1.87% YoY in Jun-25 (vs 1.60% in May-25), slightly above expectations (1.83%) but still within BI's 1.5–3.5% target. Price increases were led by food (+1.99%), housing (+1.59%), health (+1.84%), and clothing (+1.01%), while transport (+0.15%) and furnishing (+0.57%) saw slower gains. Core inflation eased to 2.37% (vs 2.40% inMay-25), marking a five-month low and below the 2.44% forecast. On a monthly basis, CPI rose +0.19% MoM, rebounding from a -0.37% decline in May-25. (Trading Economics)

COMPANY 
Bank Mandiri (BMRI) Disbursed IDR 20.19 Tn KUR to Over 173,000 Entrepreneurs 
BMRI has disbursed IDR 20.19 tn in Kredit Usaha Rakyat (KUR) to more than 173,000 entrepreneurs across Indonesia by the end of May25. The KUR is part of the bank's efforts to support productive sectors such as agriculture, fisheries, production services, and the processing industry. It is aimed at enhancing MSME growth and competitiveness, with 52.45% of the total KUR target for 2025 (IDR 38.5 tn) already achieved. (Kompas) 

Prodia (PRDA) Acquired 30% Stake in Biotechnology Company 
PRDA has acquired a 30% stake in PT Prodia StemCell Indonesia (ProSTEM), a pioneer in stem cell-based regenerative therapy in Indonesia. This acquisition involves 69,512 shares and aims to strengthen Prodia's ecosystem of personalized, innovative healthcare services. The move aligns with Prodia's long-term vision to expand beyond diagnostics into high-tech healthcare integration. ProSTEM's 46% YoY revenue growth in 2024 signals strong market potential for regenerative therapy services in Indonesia and Southeast Asia. (Emitennews)